ATTO (Attovia Therapeutics) OCF Margin %: -3,731.33% (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ATTO Attovia Therapeutics Inc ATTO
8 GF Score
Price $21.30
! 1 Warning Sign
View Full Analysis

What is Attovia Therapeutics OCF Margin %?

Attovia Therapeutics ATTO -3.66% 8 OCF Margin % is -3,731.33% as of Jun. 2026. GuruFocus rates ATTO with a GF Score™ of 8/100. The stock has 1 warning sign investors should review. Among 974 Biotechnology companies, Attovia Therapeutics ranks worse than 92.09% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Attovia Therapeutics's Cash Flow from Operations for the three months ended in Jun. 2026 was $-16.79 Mil. Attovia Therapeutics's Revenue for the three months ended in Jun. 2026 was $0.45 Mil. Therefore, Attovia Therapeutics's OCF Margin % for the quarter that ended in Jun. 2026 was -3,731.33%.

As of today, Attovia Therapeutics's current OCF Yield % is -3.59%.

The historical rank and industry rank for Attovia Therapeutics's OCF Margin % or its related term are showing as below:

ATTO' s OCF Margin % Range Over the Past 10 Years
Min: -4385.11   Med: -4385.11   Max: -4385.11
Current: -7762.67

During the past 2 years, the highest OCF Margin % of Attovia Therapeutics was -4385.11%. The lowest was -4385.11%. And the median was -4385.11%.

ATTO's OCF Margin % is ranked worse than
92.09% of 974 companies
in the Biotechnology industry
Industry Median: -70.935 vs ATTO: -7762.67

Attovia Therapeutics OCF Margin % Related Terms

Attovia Therapeutics OCF Margin % Historical Data

* Premium members only.

The historical data trend for Attovia Therapeutics's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Attovia Therapeutics OCF Margin % Chart

Attovia Therapeutics Annual Data
Trend Dec24 Dec25
OCF Margin %
- -4,385.11

Attovia Therapeutics Quarterly Data
Mar25 Jun25 Mar26 Jun26
OCF Margin % - - - -3,731.33

ATTO vs TBPH, ACRS, OLMA: OCF Margin % Comparison

For the Biotechnology subindustry, Attovia Therapeutics's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Attovia Therapeutics OCF Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Attovia Therapeutics's OCF Margin % distribution charts can be found below:

* The bar in red indicates where Attovia Therapeutics's OCF Margin % falls into.


ATTO
8GF Score
Attovia Therapeutics Inc ATTO
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Attovia Therapeutics OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Attovia Therapeutics's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-59.199/1.35
=-4,385.11 %

Attovia Therapeutics's OCF Margin for the quarter that ended in Jun. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Jun. 2026 )/Revenue (Q: Jun. 2026 )
=-16.791/0.45
=-3,731.33 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of -3,731.33% mean?
Attovia Therapeutics (ATTO) has a OCF Margin % of -3,731.33% as of Jun. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Attovia Therapeutics and its competitors. According to the industry distribution chart, Attovia Therapeutics ranks #897 out of 974 companies in the Biotechnology industry, placing it in the top 92.1%.
Is Attovia Therapeutics' OCF Margin % too high?
Attovia Therapeutics' current OCF Margin % is -3,731.33%. Based on the distribution chart, Attovia Therapeutics ranks #897 out of 974 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Attovia Therapeutics has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Attovia Therapeutics' OCF Margin % compare to TBPH and ACRS?
According to the Biotechnology industry distribution chart, Attovia Therapeutics ranks #897 out of 974 companies for OCF Margin %. This places Attovia Therapeutics in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Attovia Therapeutics and its competitors. Attovia Therapeutics's current OCF Margin % is -3,731.33%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Attovia Therapeutics stock overvalued right now?
Attovia Therapeutics (ATTO) has a current OCF Margin % of -3,731.33%. The current OCF Margin % is -3,731.33%. Attovia Therapeutics' overall GF Score™ is 8/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Attovia Therapeutics (ATTO), the current OCF Margin % is -3,731.33% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Attovia Therapeutics Business Description

Attovia Therapeutics Inc is a clinical stage biotechnology company focused on research and development of therapeutic products in the fields of immune-mediated diseases. Its product pipeline includes ATTO-1310 and ATTO-2306 for immune-dermatology indications and ATTO-1091 for inflammatory diseases, including inflammatory bowel disease (IBD). The company's product candidates are developed using its ATTOBODY biologics platform.
8GF Score

Get the complete analysis for ATTO

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.30
Price